Videos

Strategies for pediatric-specific care are explored, with an emphasis on vaccine advocation and administration geared toward parents and caregivers.

Ed Cohen, PharmD, FAPhA, drives a discussion around the new inclusion of infants as young as 6 months old within the COVID-19 vaccine recommendations and how to educate parents on the topic.

Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, discussed how mRNA vaccines could change the treatment landscape for respiratory illnesses.

Douglas Hoey, PharmD, MBA, CEO of National Community Pharmacists Association (NCPA), discusses potential causes and solutions for the current staffing issues facing so many community pharmacies.

Andrew Barnell, MBA, CEO and co-founder of Geneoscopy, discusses his meeting at the White House on President Biden’s Cancer Moonshot initiative.

Dr. Christina Madison, The Public Health Pharmacist, was recently on Good Morning America discussing the do's and don'ts of expired medications.

Drs Lodise and Feuerstadt discuss risk factors for C. difficile infection (CDI).

A gastroenterologist, Dr. Paul Feuerstadt, provides an overview of C. difficile infection (CDI) and vegetative and spore phases of CDI.

Rajul A. Patel, PharmD, PhD, director of the Medicare Part D Outreach Clinics at the University of the Pacific in Stockton, California, discusses his work providing drug savings advice to Medicare beneficiaries in diverse communities.

Pharmacies can play a key role in supporting patients with opioid use disorder and helping diminish stigma for patients treated with methadone, who are told by some they are still addicts despite trying to receive help.

Pharmacists discuss barriers contributing to vaccine reluctance among young adults, including varying degrees of education, accessibility, and convenience.

The expert panel illustrate the changing roles of pharmacists and technicians as healthcare expands and evolves from the impact of the COVID-19 pandemic.

Xenia Tigno, PhD, and Reshma Jagsi, MD, DPhil, discuss how professional and societal pressures around the legitimacy of maternal leave versus paternal leave can impact the trajectory of women’s careers in medical research.

Although the guidance has created some confusion around pharmacists’ responsibilities on the federal and state levels, Lanton said it will take time to find cohesive solutions.

Heidi D. Finnes, PharmD, BCOP, FHOPA, current president of Hematology/Oncology Pharmacy Association (HOPA), explains how HOPA can help prepare PGY2 pharmacy residents to obtain and maintain their BCOP certification.

In addition to expanding patient access to Paxlovid, the recent authorization of pharmacists to prescribe the drug marks a step toward provider status.

Xenia Tigno, PhD, and Reshma Jagsi, MD, DPhil, discuss how the pandemic impacted women’s careers in medical research and other medical fields.

The panel of pharmacists discuss the immunization tracker registry and emphasize utilizing this tool in preparation for the coming flu season.

Key opinion leaders discuss common narratives and concerns regarding a variety of vaccines and share successful strategies to overcome vaccine reluctance.

Michael Ganio, PharmD, MS, BCPS, FASHP, senior director of pharmacy practice and quality at ASHP, discussed the declaration of monkeypox as a public health emergency

Drs Haumschild, Moore, and Dent provide strategies to optimize current and forthcoming HR+/HER2– breast cancer therapies while preserving patients’ quality of life.

Experts share forthcoming treatment options in the treatment of HR+/HER2– breast cancer.

Exploring the significant role of electronic medical records (EMR) in toxicity management for patients with HR+/HER2– breast cancer.

There is nothing that hurts us more when a pharmacist stands up and is not passionate about the job that we do and the care that we provide.

Evolutionary vaccine technologies driven by the COVID-19 pandemic are explored in a discussion led by Dr Cohen.

Pharmacists highlight patient hesitations surrounding vaccinations and offer a multitude of approaches for alleviating these concerns.

Insights on unmet needs in HR-positive, HER2-negative treatment management and on how pharmacists can optimize treatment strategies and patient outcomes.

The panel highlights opportunities for inclusive populations within trials for HR+/HER2- breast cancer, as well as pharmacist-led initiatives in clinical trial settings.

The first thing is educating these folks, because it's hard for them to understand our challenges if they don’t understand what we do.

Get involved, attend their sessions, attend their conferences, understand what they’re saying, make sure that we’re, again, speaking with that one common voice.